Summary of JD Health International (6618.HK) Conference Call Company Overview - **Company**: JD Health International (6618.HK) - **Industry**: Healthcare Technology Key Financial Highlights - **2H25 Revenue**: Rmb38.2 billion, up 28% year-over-year (yoy), exceeding expectations by 5% compared to Goldman Sachs estimates and Visible Alpha Consensus Data [1] - **Non-IFRS Net Profit**: Rmb3 billion, a 38% yoy increase, beating estimates by 16% and 5% [1] - **Adjusted Net Profit Margin**: 7.8%, the highest margin for 2H in the company's history, with gross margin improving to 24.4%, up 0.8 percentage points from estimates [1] - **4Q25 Projections**: Revenue growth expected at 27% yoy and adjusted net profit growth at 30% yoy [1] Growth Drivers and Outlook - **Management Confidence**: Sustained growth momentum with FY26 revenue guidance of high-teens to 20% yoy, driven by strong drug and nutrition product sales, as well as advertising growth [2] - **Drug Sales Growth**: Expected to grow approximately 25% yoy in FY26, supported by original drugs and strong user mindshare [2] - **Nutrition Products**: Targeting around 15% yoy growth in FY26, benefiting from resource allocation and successful collaborations [2] - **Medical Devices**: Anticipated growth of about 10% yoy for FY26, reflecting steady industry growth [2] Margin and Profitability Insights - **Adjusted Operating Profit Margin**: Expected to remain at least flat yoy in FY26, benefiting from improved gross margins and advertising revenue growth [2] - **Investment in Technology**: Continuous improvement in gross margins is anticipated despite rising expenses due to investments in on-demand delivery and AI initiatives [2] Investment Rating and Price Target - **Rating**: Buy - **12-Month Target Price**: HK$75 per share, implying a 57.9% upside from the current price of HK$47.50 [3][9] Risks and Challenges - **Sales Growth Risks**: Potential for slower-than-expected sales growth in 2026, particularly in drug and non-drug categories [3][6] - **Margin Dynamics**: Concerns regarding margin dynamics due to ongoing investments in technology and competition from online pharmacies and e-commerce peers [6] Additional Financial Metrics - **Market Capitalization**: HK$151.5 billion / $19.4 billion [9] - **Revenue Forecasts**: Projected revenues for FY26 are Rmb83.1 billion, with EBITDA expected to reach Rmb4.1 billion [9] - **P/E Ratio**: Expected to be 19.1x in FY26 [9] Conclusion - JD Health International demonstrates strong financial performance with significant revenue and profit growth, driven by robust sales in drug and nutrition categories. The company maintains a positive outlook for FY26, although it faces potential risks related to sales growth and competitive pressures. The investment rating remains bullish with a substantial upside potential.

Core Insights - Uber is expanding its grocery and alcohol retail partnerships with new regional additions, including Stater Bros. Markets, Kowalski's Markets, and Big Red Liquors, enhancing its local offerings across the U.S. [1][4] Group 1: New Partnerships - The new partnerships will allow customers in Southern California, Minnesota, and the Midwest to access more regional favorites through the Uber and Uber Eats apps [2][4] - Stater Bros. is recognized for its high-quality meats and produce, Kowalski's for its gourmet selections, and Big Red for its local wines and craft spirits, catering to holiday hosting needs [3][4] Group 2: Growth in Retail Business - 2025 has been a significant year for Uber's grocery and retail business, with over 1,000 new retailers added globally and more than 50,000 retail locations across the U.S. [4][5] - The expansion includes well-known national brands alongside regional partners, emphasizing the importance of local brands in community identity [5][4] Group 3: Customer Experience - Uber One members benefit from $0 Delivery Fees on eligible grocery and retail orders, enhancing the shopping experience [3][4] - The process for customers includes selecting local stores, adding items to the cart, and tracking orders in real-time [7]

Summary of Key Findings from the Survey on Chinese On-Demand Delivery Behavior Industry Overview - **Industry**: Chinese On-Demand Delivery Services - **Survey Conducted By**: Citi's Innovation Lab - **Sample Size**: 1,800 users in China - **Survey Period**: June-July 2025 Core Findings 1. **Increased Order Frequency**: - 47% of daily users reported an increase in order frequency over the past three months, primarily due to more discounts and promotions [1][3][18] 2. **Leading Platforms**: - **Meituan**: Dominates the market with 68% of users for food delivery and 72% for non-food categories, attributed to the variety of restaurant choices [1][4][75] - **Taobao Shangou**: Captures a higher percentage of female users and younger demographics, achieving the highest Net Promoter Score (NPS) at 70 [1][5][49] - **JD Takeaway**: Despite being available for less than six months, it was used by 61% of respondents [1][75] - **Ele.me**: Holds a smaller market share with 13% for food delivery [4][41] 3. **User Demographics**: - 56% of respondents order food for themselves, while 36% order for two people [35] - The age distribution shows Taobao Shangou attracting younger users (37% aged 18-29), while Meituan is favored by older users (45-59 and 60+) [49][54] 4. **Spending Patterns**: - Average spending per order: - Food delivery: Rmb30-49 for 46% of users, Rmb10-29 for 33% [2][32] - Non-food delivery: Average spending at Rmb180, with 43% spending Rmb50-149 [62][63] 5. **Order Timing**: - Most common ordering times: 72% for lunch, 56% for dinner, and notable percentages for afternoon tea (35%) and supper (27%) [34][75] 6. **Reasons for Choosing Delivery Services**: - Availability of restaurants is the most important factor (43%), followed by delivery speed (21%) and price (19%) [33][41] 7. **Expectations for Future Ordering**: - 39% of users expect to order somewhat more this year, while 42% plan to maintain their current frequency [22][25] Additional Insights - **Concerns Affecting Order Frequency**: - Users ordering less frequently cited food safety (42%) and decreased food quality (32%) as primary concerns [19][24] - **Market Dynamics**: - The total addressable market (TAM) and higher penetration rates are expected to sustain despite normalizing subsidies, indicating a positive trend for profitability across platforms [74] - **Competitive Landscape**: - Meituan's strength lies in its extensive restaurant options, while JD is recognized for faster delivery and customer service [43][54] Conclusion - The survey indicates a robust growth trajectory for the on-demand delivery market in China, with Meituan and Taobao Shangou leading in user preference and satisfaction. The findings suggest a competitive landscape where user behavior is influenced by promotions, service quality, and product availability, with expectations for continued growth in order frequency and market penetration.